Boston, MA -- (SBWIRE) -- 12/16/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: NanoTech Entertainment, Inc. (OTCMKTS:NTEK), XUMANII INTERNATION (OTCMKTS:XUII), Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT)
NanoTech Entertainment, Inc. (OTCMKTS:NTEK) increased 3.63% at the price of $0.140 recently on a traded volume of 2.82 million shares, in comparison to 5.07 million shares of average trading volume. So far this year, the stock is up over 8643.75%.
The company has a total market capitalization of $73.91 million and its total outstanding shares are 528.29 million. NanoTech Entertainment, Inc. (NanoTech), formerly Aldar Group, Inc., is a provider of gaming technology for the coin-op arcade, casino gaming and consumer gaming markets.
For How Long NTEK will Fight for Profitability? Read This Trend Analysis report
XUMANII INTERNATION (OTCMKTS:XUII) soared 5.57% at the trading price of $0.0588 on a traded volume of 3.83 million shares till now, whereas its average trading volume is 2.46 million shares. In the last three months, the stock is up 102.76%. The Intra-day range for the stock is $0.06 and $0.07. Xumanii International Holdings Corp develops RFID scanners under the Mi name. Its Mi scanners include the ability to scan RFID, one and two dimensional bar codes, and mag stripes from one device approximately the size of a smart phone.
For How Long XUII Gloss will Attract Investors? Find out via this report
Deutsche Telekom AG (ADR) (OTCMKTS:DTEGY) jumped up 3.65% at the $16.19 recently. So far in three months, the stock is up 21.55%. The 52-week range for the stock is $10.37 and $16.50. Its introductory price for the day was $16.16, with the overall traded volume of 206,839.00 shares. Deutsche Telekom AG is a Germany-based integrated telecommunications provider offering its customers a portfolio of services in the areas of telecommunications and information technology (IT).
Will DTEGY Continue To Move Higher? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) after opening its shares at the price of $1.60, dropped -4.55% , its recent trading price was $1.47 for the day. The stock moved on a traded volume of 1.62 million shares, in comparison to 750,548.00 shares of average trading volume.
The 52-week range for the stock is $0.53 and $1.63. Its introductory price for the day was $1.60. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications.
Will PVCT Get Buyers Even After The Recent Rally? Find Out Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)